Neonatal sepsis is the cause of substantial morbidity and mortality. Precise estimates of
neonatal sepsis burden vary by setting. Differing estimates of disease burden have been …

Early-onset sepsis remains a common and serious problem for neonates, especially preterm
infants. Group B streptococcus (GBS) is the most common etiologic agent, while Escherichia …

Importance Extremely preterm infants contribute disproportionately to neonatal morbidity
and mortality. Objective To review 20-year trends in maternal/neonatal care, complications …

This is the eighteenth global report on tuberculosis (TB) published by WHO in a series that
started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic …

With improved obstetrical management and evidence-based use of intrapartum
antimicrobial therapy, early-onset neonatal sepsis is becoming less frequent. However, early …

Importance Early-onset sepsis (EOS) remains a potentially fatal newborn condition. Ongoing
surveillance is critical to optimize prevention and treatment strategies. Objective To describe …

BACKGROUND: Group B Streptococcus (GBS) and Escherichia coli have historically
dominated as causes of early-onset neonatal sepsis. Widespread use of intrapartum …

Abstract Background Group B Streptococcus (GBS) remains a leading cause of neonatal
sepsis in high-income contexts, despite declines due to intrapartum antibiotic prophylaxis …

Neonatal sepsis remains a feared and serious complication, especially among very low birth
weight (VLBW) preterm infants. Neonatal sepsis is divided into early-onset and late-onset …

Importance Current algorithms for management of neonatal early-onset sepsis (EOS) result
in medical intervention for large numbers of uninfected infants. We developed multivariable …